Single B Cell Technology Accelerated Lead Antibody Molecules Discovery

Webinar Schedule

October 9th, 2024

Webinar Registration

The webinar will be held three to accommodate our global audience.

Register for the 3:00 pm JST/KST webinar

Register for the 3:00 pm CET webinar

Register for the 1:00 pm PDT/ 4:00 pm EDT webinar

Abstract

Single B cell antibody discovery technology is a powerful approach for isolating and characterizing antibodies from individual B cells. This method leverages microfluidics and high-throughput sequencing technologies to efficiently screen and clone antibodies with high specificity and affinity.

Compared with traditional hybridoma technology and phage display technology, the single B cell antibody technology boasts advantages such as a shorter development cycle, high throughput, numerous positive clones, and high affinity. Most importantly, antibodies obtained through this technique ensure the natural pairing of light and heavy chains.

In this webinar, we will discuss the background and technical details of single B cell technology. In addition, we will cover features of single B technology from Cusabio and demonstrate a case study from Cusabio for maximizing your antibody screening success.

Key Content

1. Single B cell antibody discovery introduction

2. Cusabio single B platform features and solutions

3. Case study of antibody molecules discovery from Cusabio

Speaker

Ying Zhou PhD

Product Manager, CUSABIO

Dr. Ying Zhou is a Product Manager at CUSABIO, responsible for product marketing, development, and optimization. Before joining CUSABIO, Dr. Zhou earned her Ph.D. in Biology and Biotechnology from Worcester Polytechnic Institute in the United States. Following her graduation, she pursued post-doctoral training at the University of California, Davis. Dr. Zhou's expertise lies in molecular biology and protein science, specifically in mRNA expression and regulation. She is particularly interested in mRNA stability and RNA-interacting proteins.